1.97
-0.05(-2.48%)
Currency In USD
| Previous Close | 2.02 |
| Open | 2.02 |
| Day High | 2.04 |
| Day Low | 1.95 |
| 52-Week High | 70.14 |
| 52-Week Low | 1.71 |
| Volume | 19,997 |
| Average Volume | 68,462 |
| Market Cap | 1.78M |
| PE | -0.01 |
| EPS | -250.62 |
| Moving Average 50 Days | 2.35 |
| Moving Average 200 Days | 13.55 |
| Change | -0.05 |
If you invested $1000 in Nuwellis, Inc. (NUWE) 10 years ago, it would be worth $0 as of January 14, 2026 at a share price of $1.97. Whereas If you bought $1000 worth of Nuwellis, Inc. (NUWE) shares 5 years ago, it would be worth $0 as of January 14, 2026 at a share price of $1.97.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Nuwellis Announces Issuance of New U.S. Patent Supporting Advanced Safety Design for Pediatric Extracorporeal Therapy
GlobeNewswire Inc.
Jan 06, 2026 1:15 PM GMT
Patent issuance strengthens pediatric intellectual property portfolio and advances system-level safety designMINNEAPOLIS, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company advancing precision fluid manage
Lenox Hill Hospital Study Highlights the Broad Utility of Aquadex in Managing Fluid Overload Across Critical Care Settings
GlobeNewswire Inc.
Dec 09, 2025 1:15 PM GMT
Findings reinforce Nuwellis’ leadership in precision ultrafiltration for patients with acute kidney injury and fluid overload.MINNEAPOLIS, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to de
Nuwellis Continues Clinician-Driven Growth in Pediatric Care with a Leading Hospital in the Northeast U.S.
GlobeNewswire Inc.
Dec 04, 2025 1:15 PM GMT
Pediatric nephrology and cardiology teams continue to seek out Aquadex for safe, precise fluid management in complex casesMINNEAPOLIS, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delive